The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening disease. However, there are only few epidemiologic studies of SJS/TEN from China. To analyze the clinical characteristics, causality, and outcome of treatment for SJS/TEN in China, we reviewed case reports of pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Shang-Chen Yang, Sindy Hu, Sheng-Zheng Zhang, Jin-wen Huang, Jing Zhang, Chao Ji, Bo Cheng
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2018/4320195
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558516720631808
author Shang-Chen Yang
Sindy Hu
Sheng-Zheng Zhang
Jin-wen Huang
Jing Zhang
Chao Ji
Bo Cheng
author_facet Shang-Chen Yang
Sindy Hu
Sheng-Zheng Zhang
Jin-wen Huang
Jing Zhang
Chao Ji
Bo Cheng
author_sort Shang-Chen Yang
collection DOAJ
description Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening disease. However, there are only few epidemiologic studies of SJS/TEN from China. To analyze the clinical characteristics, causality, and outcome of treatment for SJS/TEN in China, we reviewed case reports of patients with SJS/TEN from the China National Knowledge Infrastructure (CNKI) and Wanfang database from 2006 to 2016 and patients with SJS/TEN who were admitted to the First Affiliated Hospital of Fujian Medical University during the same period. There were 166 patients enrolled, including 70 SJS, 2 SJS/TEN overlap, and 94 TEN. The most common offending drugs were antibiotics (29.5%) and anticonvulsants (24.1%). Carbamazepine, allopurinol, and penicillins were the most common single offending drugs (17.5%, 9.6%, and 7.2%). Chinese patent medicines accounted for 5.4%. There were 76 (45.8%) patients receiving systemic steroid and intravenous immunoglobulin (IVIG) in combination therapy, especially for TEN (80.3%), and others were treated with systemic steroids alone. Mortality rate of combination treatment comparing with steroid alone in TEN patients had no statistical significance. In conclusion, carbamazepine and allopurinol were the leading causative drugs for SJS/TEN in China. Combination of IVIG and steroids is a common treatment for TEN, but its efficacy in improving mortality needs further investigation.
format Article
id doaj-art-3fbc7946404c4fe0be6a5a3b69cdb0d9
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-3fbc7946404c4fe0be6a5a3b69cdb0d92025-02-03T01:32:07ZengWileyJournal of Immunology Research2314-88612314-71562018-01-01201810.1155/2018/43201954320195The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in ChinaShang-Chen Yang0Sindy Hu1Sheng-Zheng Zhang2Jin-wen Huang3Jing Zhang4Chao Ji5Bo Cheng6Department of Dermatology, Xiamen Chang Gung Hospital, Xiamen, Fujian, ChinaDepartment of Dermatology, Xiamen Chang Gung Hospital, Xiamen, Fujian, ChinaDepartment of Dermatology, Xiamen Chang Gung Hospital, Xiamen, Fujian, ChinaDepartment of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, ChinaDepartment of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, ChinaDepartment of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, ChinaDepartment of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, ChinaStevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening disease. However, there are only few epidemiologic studies of SJS/TEN from China. To analyze the clinical characteristics, causality, and outcome of treatment for SJS/TEN in China, we reviewed case reports of patients with SJS/TEN from the China National Knowledge Infrastructure (CNKI) and Wanfang database from 2006 to 2016 and patients with SJS/TEN who were admitted to the First Affiliated Hospital of Fujian Medical University during the same period. There were 166 patients enrolled, including 70 SJS, 2 SJS/TEN overlap, and 94 TEN. The most common offending drugs were antibiotics (29.5%) and anticonvulsants (24.1%). Carbamazepine, allopurinol, and penicillins were the most common single offending drugs (17.5%, 9.6%, and 7.2%). Chinese patent medicines accounted for 5.4%. There were 76 (45.8%) patients receiving systemic steroid and intravenous immunoglobulin (IVIG) in combination therapy, especially for TEN (80.3%), and others were treated with systemic steroids alone. Mortality rate of combination treatment comparing with steroid alone in TEN patients had no statistical significance. In conclusion, carbamazepine and allopurinol were the leading causative drugs for SJS/TEN in China. Combination of IVIG and steroids is a common treatment for TEN, but its efficacy in improving mortality needs further investigation.http://dx.doi.org/10.1155/2018/4320195
spellingShingle Shang-Chen Yang
Sindy Hu
Sheng-Zheng Zhang
Jin-wen Huang
Jing Zhang
Chao Ji
Bo Cheng
The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
Journal of Immunology Research
title The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
title_full The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
title_fullStr The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
title_full_unstemmed The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
title_short The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
title_sort epidemiology of stevens johnson syndrome and toxic epidermal necrolysis in china
url http://dx.doi.org/10.1155/2018/4320195
work_keys_str_mv AT shangchenyang theepidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT sindyhu theepidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT shengzhengzhang theepidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT jinwenhuang theepidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT jingzhang theepidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT chaoji theepidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT bocheng theepidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT shangchenyang epidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT sindyhu epidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT shengzhengzhang epidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT jinwenhuang epidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT jingzhang epidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT chaoji epidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina
AT bocheng epidemiologyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisinchina